Startups
AI drug development startup Pathos AI closes $237M investment
AI drug development startup Pathos AI raises $237 million in Series E funding at a $3 billion valuation, led by Bristol Myers Squibb.
Topic
#Pathos Ai
Stories tagged by our AI curator.